International Journal of Radiation Oncology*Biology*Physics
Original contributionTumor heterogeneity, tumor size, and radioresistanceā
References (87)
The genetic control of radiation sensitivity in micro-organisms
Adv. Radiat. Biol.
(1966)- et al.
Cell death in normal and malignant tissue
Adv. Cancer Res.
(1975) - et al.
Inherent cellular radiosensitivity as a basic concept for human tumor radiotherapy
Int. J. Radiat. Oncol. Biol. Phys.
(1981) - et al.
Tumor supressors: recessive mutations that lead to cancer
Cell
(1988) - et al.
Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck
Radiother. Oncol.
(1985) - et al.
The influence of the number of fractions and overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx
Int. J. Radiat. Oncol. Biol. Phys.
(1983) - et al.
Clinical trial of 252 Cf neutron brachytherapy vs. conventional radiotherapy for advanced cervical cancer
Int. J. Radiat. Oncol. Biol. Phys.
(1985) Late effects of chemotherapy and radiation therapy: a new hypothesis
Int. J. Radiat. Oncol. Biol. Phys.
(1984)- et al.
High dose radiation therapy in the treatment of glioblastoma. multiforme: a preliminary report
Int. J. Radiat. Oncol. Biol. Phys.
(1976) Gene amplification in cultured animal cells
Cell
(1984)
Faster repair of DNA double-strand breaks in radioresistant human tumor cells
Int. J. Radiat. Oncol. Biol. Phys.
Radiation resistance in a multidrug resistant human T-cell leukemia cell line
Int. J. Radiat. Oncol. Biol. Phys.
Tumor persistance as a predictor of outcome after radiation therapy of head and neck cancer
Int. J. Radiat. Oncol. Biol. Phys.
Impact of improved local control on survival
Int. J. Radiat. Oncol. Biol. Phys.
Proto-oncogene fos: complex but versitile regulation
Cell
Re-irradiation of recurrent nasopharyngeal carcinomas-treatment techniques and results
Int. J. Radiat. Oncol. Biol. Phys.
Radioresistant and repair proficient cells may determine radiocurability of human tumors
Int. J. Radiat. Oncol. Biol. Phys.
Heterogeneity of radiation response of a parent human epidermoid carcinoma and four clones
Int. J. Radiat. Oncol. Biol. Phys.
Some implications of the linear-quadratic model for tumor control probability
Int. J. Radiat. Oncol. Biol. Phys.
Drug and radiation sensitivity measurements of successful primary monolayer culture of human tumor cells using cell-adhesive matrix and supplemental medium
Cancer Res.
Mutation selection and the natural history of cancer
Nature
Increasing metastatic-potential is associated with increasing genetic instability of clones isolated from murine neoplasms
A mathematical model of drug resistance
Radioresistant mutants of L5178Y cells
Radiat. Res.
Mutator strains of escherichia coli mutD and dnaQ with defective exonuclease editing by DNA polymerase III holoenzyme
Repair processes in radiation biology
Radiat. Res.
The multistep nature of cancer development
Cancer Res.
Biological diversity in metastatic neoplasms: origins and implications
Science
Metastasis results from pre-existing variant cells within a malignant tumor
Science
Lung cancer heterogeneity, prognostic implications
Cancer
R46 and PKM 101 plasmid-mediated resistance to ionizing radiation in escherichia coli
Radiat. Res.
A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate
Cancer Treat. Rep.
Quantitative model for multiple levels of drug resistance in clinical tumors
Cancer Treat. Rep.
The genetic origin of drug resistant neoplasms: implication for systematic therapy
Cancer Res.
Applications of theoretical models to chemotherapy protocal design
Cancer Treat. Rep.
Growth factors and cancer
Cancer Res.
Metastatic variants are generated spontaneously at a high rate in mouse KHT tumor
Tumor heterogeneity
Cancer Res.
Acquired radioresistance of transplantable mammary adenocarcinoma in inbred mice after. serial irradiation
Radiology
Loss of epidermal growth factor receptor gene amplifications as malignant human gliomas are established in culture (Abstract)
Cancer: cell growth and control mechanisms
Nature
Multiple small exposures of far and mid-ultraviolet light change the sensitivity to acute ultraviolet exposures measured by cell le thality and mutagenesis in V79 Chinese hamster cells
Radiat. Res.
Cited by (63)
The genetic landscape of 87 ovarian germ cell tumors
2018, Gynecologic OncologyCitation Excerpt :A limited number of mutations are sufficient to develop an oncogenic phenotype, early as well as advanced/metastatic disease. The low mutation rate might also explain the chemo-sensitivity even in advanced or recurrent disease [22]. Due to the low number of somatic mutations, OGCTs are less likely to harbor clones with drug resistance.
Exome-wide sequencing shows low mutation rates and identifies novel mutated genes in seminomas
2015, European UrologyCitation Excerpt :While higher than previous estimates based on very limited data [11], the mutation rates in seminomas are nevertheless much lower than the rates observed in many other cancers (Fig. 3) [35]. The low numbers of mutations in seminomas might be related to their sensitivity to therapy [6]. Most advanced-stage cancers are incurable, even with aggressive chemotherapy; although chemotherapy can lead to initial disease regression, the cancer invariably becomes resistant to drug treatment, and patients ultimately succumb to the disease.
Isolation and characterization of radiation-resistant lung cancer D6-R cell line
2008, Biomedical and Environmental SciencesCurrent clinical results of the Tsukuba BNCT trial
2004, Applied Radiation and IsotopesPrimary tumor volume of nasopharyngeal carcinoma: Prognostic significance for local control
2004, International Journal of Radiation Oncology Biology PhysicsThe Molecular and Cellular Strategies of Glioblastoma and Non-Small-Cell Lung Cancer Cells Conferring Radioresistance
2022, International Journal of Molecular Sciences
- ā
Preliminary versions of this work were presented at the Meetings of the Radiological Society of North America, Chicago, IL, November 29-December 4, 1987, the Radiation Research Society, Philadelphia, PA, April 16ā21, 1988 and the American Society of Therapeutic Radiology and Oncology, New Orleans, LA, October 9ā14, 1988.